权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Therapeutic efficacy of Ibudilast to attenuate inflammation at the synapse

异丁司特减轻突触炎症的治疗功效

基本信息

批准号：
9904613
负责人：
Gurudutt N Pendyala
金额：
$ 19.06万
依托单位：
UNIVERSITY OF NEBRASKA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-04-15 至 2022-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9904613
关键词：
AMPA Receptors Address Animal Model Anti-Inflammatory Agents Architecture Area Astrocytes Attenuated Biochemical Biological Models Biology Brain region Cells Characteristics Chronic Communication Complement Contracts Dendritic Spines Down-Regulation Drug abuse Electrophysiology (science)Enzyme-Linked Immunosorbent Assay Functional disorder Funding Mechanisms Glutamate Transporter Glutamates Goals HIV HIV Envelope Protein gp120 HIV Infections HIV-associated neurocognitive disorder High Pressure Liquid Chromatography IL6 gene Image In Vitro Inflammation Inflammatory Inflammatory Response Injury Lighting Measures Mediating Methamphetamine Microglia Microscopy N-Methyl-D-Aspartate Receptors N-Methylaspartate Nature Needle Sharing Neuraxis Neuroglia Neurologic Neurons Outcome Pathway interactions Pharmaceutical Preparations Phosphatidylethanolamine Binding Protein Phosphodiesterase Inhibitors Physiology Play Production Proteins Rattus Regimen Research Research Personnel Rewards Risk Role Series Small Interfering RNA Structure Synapses Synaptic Potentials TNF gene Testing Therapeutic Toxic effect Treatment Efficacy Treatment Protocols Western Blotting Work base brain dysfunction cytokine efficacy testing excitotoxicity experimental study extracellular glial activation in vitro Model in vivo knock-down methamphetamine abuse molecular imaging neuroAIDS neurotransmission pre-clinical receptor response therapeutic evaluation vesicular glutamate transporter 1

项目摘要

Abstract Despite earlier studies that have shown the overall impact of inflammation and excitotoxicity induced by HIV and methamphetamine (meth) in the progression of HIV-Associated Neurocognitive Disorders, a significant gap that remains is identifying synaptic protein targets including their modulation by therapeutic drugs to ameliorate such inflammatory responses and glutamate excitotoxicity at the synapse. This R21 proposal focuses on one such synaptic target phosphatidylethanolamine-binding protein 1 (PEBP1) which we have identified from a previous study and whose reduced expression by HIV (Tat, gp120) and meth was reversed by treatment with the anti- inflammatory drug Ibudilast, a phosphodiesterase inhibitor. Based on the synaptic localization of PEBP1, we tested a more causal effect of knock down of PEBP1 using siRNA on mixed cerebrocortical cultures that comprise of differentiating neurons and astrocytes. We treated 14 days in vitro (DIV14) mixed cerebrocortical cultures with siRNA against PEBP1 followed by Tat/meth treatments alone and in combination for 24h. In parallel, a subset of 24h Tat/meth treated cultures were given ibudilast treatment for 24h. Tat and meth in combination decreased the expression of the glutamate transporter EAAT2 and a concurrent increase in the vesicular glutamate transporter 1 (vGLUT1) in the lysates by western blot thus suggesting excitotoxicity. This increase in glutamate levels corroborated with increase in the levels of the proinflammatory cytokines IL6 and TNF-in the cell supernatants as determined by ELISA. Interestingly, these effects were attenuated in cultures treated with Ibudilast for 24h. Based on the well-established dogma of inflammation and excitotoxicity by HIV and meth, we hypothesize that PEBP1 down regulation by HIV and meth increases inflammation and glutamate toxicity thus exacerbating synaptodendritic damage which can be reversed by ibudilast treatment. We will examine our hypothesis in an in vitro model of mixed cerebrocortical cultures complemented by a tractable preclinical animal model system HIV-Tg rat using biochemical, molecular, imaging and electrophysiological approaches. To summarize, our studies have identified a potential synaptic protein target and an anti-inflammatory drug with a therapeutic efficacy to mitigate aberrations associated with its downregulation at the synapse during HIV and meth induced CNS dysfunction.

摘要